Betamethasone could improve outcomes for prostate cancer radiation therapy
12 Aug 2022 //
NEWSWIRE
Fagron Group B.V. Receives FDA Warning Letter
29 Jun 2022 //
FDA
Padagis Announces 3 Major Product Launches
21 Jun 2022 //
FDA
Glenmark receives ANDA approval for topical treatment of plaque psoriasis
09 May 2022 //
ET HEALTH
Enforcement Report - Week of September 22, 2021
22 Sep 2021 //
FDA
EPI Health and MC2 Therapeutics announces U.S. Launch of Wynzora
19 Jul 2021 //
PRNEWSWIRE
Highly Significant Head to Head Data for Wynzora Cream
06 Jul 2021 //
ACCESSWIRE
Almirall & MC2 Therapeutics announce completion of decentralized procedure
06 Jul 2021 //
FIRSTWORDPHARMA
Lipidor, Cadila to conduct Ph III study of anti-psoriasis candidate
07 Jul 2020 //
BIOSPECTRUMASIA
Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®
02 Apr 2019 //
BIOSPACE
Recipharm Ltd. Fails EDQM Inspection
20 Oct 2018 //
EDQM
Enforcement Report - Week of March 22, 2017
22 Mar 2017 //
FDA
DoP Rejects Ranbaxy`s Review Application on Histec EVT Tabs & Fucibet Cream in 15 gm Aluminium Tube
04 Feb 2015 //
PHARMABIZ